A5031529875- Diabetes, Cardiovascular Risks, and Lipoproteins
- Peripheral Neuropathies and Disorders
- Hepatitis B Virus Studies
- Lipoproteins and Cardiovascular Health
- Biochemical and biochemical processes
- Hepatitis C virus research
- Substance Abuse Treatment and Outcomes
- Heparin-Induced Thrombocytopenia and Thrombosis
- Botulinum Toxin and Related Neurological Disorders
- Ginkgo biloba and Cashew Applications
- Global Cancer Incidence and Screening
- Diabetes Treatment and Management
- Long-Term Effects of COVID-19
- Parkinson's Disease Mechanisms and Treatments
- Diet and metabolism studies
- Allergic Rhinitis and Sensitization
- Medical Coding and Health Information
- Aging, Elder Care, and Social Issues
- Blood groups and transfusion
- Vaccine Coverage and Hesitancy
- Dermatology and Skin Diseases
- Alcohol Consumption and Health Effects
- Nutritional Studies and Diet
- Healthcare Systems and Practices
- Global Health Care Issues
l'Assurance Maladie
2013-2021
Kimberly-Clark (Canada)
2018
University of Regina
2018
Weatherford College
2018
Conservatoire National des Arts et Métiers
2015
Centre de Médecine Préventive
2015
The most used score to measure comorbidity is the Charlson index. Its application a health care administrative database including International Classification of Diseases, 10th edition (ICD-10) codes, medical procedures, and medication required studying its properties on survival. Our objectives were adapt index French National Health Insurance predict 1-year mortality discharged patients compare discrimination calibration different versions cohort included all adults from hospital stay in...
Whether human papillomavirus (HPV) vaccination could induce or trigger autoimmune diseases (AID) has been questioned, and potentially contributes to low immunization coverage in France. This study evaluated the association between HPV risk of AID using routinely collected data sources. All girls aged 13–16 years 2008 2012, covered by general health insurance scheme without history AID, were included followed French nationwide databases. Fourteen neurological, rheumatological, haematological,...
Abstract Purpose Baclofen is widely used off‐label for alcohol use disorders (AUD) in France, despite its uncertain efficacy and safety, particularly at high doses. This study was designed to evaluate the safety of this compared main approved drugs AUD (acamprosate, naltrexone, nalmefene). Methods cohort from French Health Insurance claims database included patients, aged 18 70 years, with no serious comorbidity (assessed by Charlson score) initiating baclofen or between 2009 2015. The risk...
Guillain-Barré syndrome (GBS) is potentially life threatening and typically occurs after an infection. No detailed information available concerning the epidemiological characteristics of GBS in France. We estimated age- sex-specific incidence rates (IRs) based on a French nationwide hospital discharge database. All patients hospitalized for between 2008 2013 were identified by International Classification Diseases-10 code G61.0 as principal diagnosis. Patients previously 2006 2007 excluded....
Cervical cancer screening in young women may lead to the detection of lesions with a high potential for spontaneous regression and no benefit surgery. French guidelines recommend initiating cervical by Pap test from age 25 years. To date, nationwide study has assessed related subsequent work-up surgical procedures among screen-positive women. Using data national healthcare databases (around 50 million beneficiaries), annual 3-year rates were calculated aged 15–24 years between 2007 2013....
According to guidelines, diabetic patients with high cardiovascular risk should receive a statin. Despite this consensus, fibrate monotherapy is commonly used in population. We assessed the frequency and clinical consequences of use fibrates for primary prevention diabetes risk.Retrospective cohort study based on nationwide data from medical administrative databases French national health insurance systems (07/01/08-12/31/09) follow-up up 30 months.Lipid-lowering drug-naive initiating or...